Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Gains from Investment Securities (2019 - 2020)

Burning Rock Biotech has reported Gains from Investment Securities over the past 2 years, most recently at -$1.1 million for Q4 2020.

  • For Q4 2020, Gains from Investment Securities fell 546.23% year-over-year to -$1.1 million; the TTM value through Dec 2020 reached -$555221.5, down 37.03%, while the annual FY2025 figure was $29000.0, 14.71% down from the prior year.
  • Gains from Investment Securities for Q4 2020 was -$1.1 million at Burning Rock Biotech, down from $501937.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $501937.0 in Q1 2020 and troughed at -$1.1 million in Q4 2020.